Co-ordination of hepatic and adipose tissue lipid metabolism after oral glucose

Journal of Lipid Research

Volumn 40, Issue 11, 1999, Pages 2034-2043

  Bülow, Jens ^a   Simonsen, Lene ^a   Wiggins, David ^b   Humphreys, Sandy M ^b   Frayn, Keith N ^b   Powell, David ^b   Gibbons, Geoffrey F ^b  

^a BISPEBJERG HOSPITAL   (Denmark)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Adipose tissue uptake; Apolipoprotein B; Metabolic cycling; Particle size; Splanchnic secretion; Very low density lipoproteins

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; LIPID METABOLISM; LIPOPROTEIN METABOLISM; LIVER METABOLISM; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW; SUBCUTANEOUS FAT;

ADIPOSE TISSUE; ADMINISTRATION, ORAL; ADULT; BLOOD GLUCOSE; FATTY ACIDS; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; KETONE BODIES; LIPID METABOLISM; LIPOLYSIS; LIPOPROTEIN LIPASE; LIPOPROTEINS, VLDL; LIVER; MALE; SPLANCHNIC CIRCULATION; VISCERA;

EID: 0344771679     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Farese, R. V., Jr., T. J. Yost, and R. H. Eckel. 1991. Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism. 40: 214-216.
2. Jensen, M. D., M. Caruso, V. Heiling, and J. M. Miles. 1989. Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes. 38: 1595-1601.
3. Duerden, J. M., and G. F. Gibbons. 1990. Storage, mobilization and secretion of cytosolic triacylglycerol in hepatocyte cultures. The role of insulin. Biochem. J. 272: 583-587.
4. Gibbons, G. F. 1986. Hyperlipidaemia of diabetes. Clin. Sci. 71: 477-486.
5. Gibbons, G. F. 1989. Insulin, diabetes and hepatic very-low-density lipoprotein metabolism. Biochem. Soc. Trans. 17: 49-51.
6. Bourgeois, C. S., D. Wiggins, and G. F. Gibbons. 1996. Chronic exogenous hyperinsulinaemia does not modify the acute inhibitory effect of insulin on the secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B in primary cultures of rat hepatocytes. Biochem. J. 314: 103-108.
7. Bourgeois, C. S., D. Wiggins, R. Hems, and G. F. Gibbons. 1995. VLDL output by hepatocytes from obese Zucker rats is resistant to the inhibitory effect of insulin. Am. J. Physiol. 269: E208-E215.
8. Lewis, G. F., K. D. Uffelman, L. W. Szeto, and G. Steiner. 1993. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes. 42: 833-842.
9. Malmström, R., C. J. Packard, M. Caslake, D. Bedford, P. Stewart, H. Yki-Järvinen, J. Shepherd, and M. R. Taskinen. 1998. Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes. 47: 779-787.
10. Austin, M. A., M. C. King, K. M. Vranizan, and R. M. Krauss. 1990. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk [see comments]. Circulation. 82: 495-506.
11. Havel, R. J. 1994. Postprandial hyperlipidemia and remnant lipoproteins. Curr. Opin. Lipidol. 5: 102-109.
12. Sniderman, A. D., and K. Cianflone. 1993. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler. Thromb. 13: 629-636.
13. Henriksen, J. H., and K. Winkler. 1987. Hepatic blood flow determination. A comparison of 99-Tc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man. J. Hepatol. 4: 66-70.
14. Bülow, J. 1983. Adipose tissue blood flow during exercise. Dan. Med. Bull. 30: 85-100.
15. Bülow, J., R. Jelnes, A. Astrup, and J. V. P. Madsen. 1987. Tissue/ blood partition coefficients for xenon in various adipose tissue depots in man. Stand. J. Clin. Lab. Invest. 47: 1-3.
16. Simonsen, L. 1997. The glucose-induced thermogenesis in different tissues in man. Dan. Med. Bull. 44: 56-69.
17. Elia, M., and G. Livesey. 1988. Theory and validity of indirect calorimetry during net lipid synthesis. Am. J. Clin. Nutr. 47: 591-607.
18. Coppack, S. W., R. M. Fisher, G. F. Gibbons, S. M. Humphreys, M. J. McDonough, J. L. Potts, 61nd K. N. Frayn. 1990. Postprandial substrate deposition in human forearm and adipose tissues in vivo. Clin. Sci. 79: 339-348.
19. Frayn, K. N., S. W. Coppack, S. M. Humphreys, and P. L. Whyte. 1989. Metabolic characteristics of human adipose tissue in vivo. Clin. Sci. 76: 509-516.
20. Humphreys, S. M., R. M. Fisher, and K. N. Frayn. 1990. Micromethod for measurement of sub-nanomole amounts of triacylglycerol. Ann. Clin. Biochem. 27: 597-598.
21. Duerden, J. M., and G. F. Gibbons. 1993. Restoration in vitro of normal rates of very-low-density lipoprotein triacylglycerol and apoprotein B secretion in hepatocyte cultures from diabetic rats. Biochem. J. 294: 167-171.
22. Simonsen, L., C. Ryge, and J. Bulow. 1995. Glucose-induced thermogenesis in splanchnic and leg tissues in man. Clin. Sci. Colch. 88: 543-550.
23. Frayn, K. N., B. A. Fielding, J. S. Samra, and L. K. M. Summers. 1997. Extracellular metabolic regulation in adipose tissue. In Physiology, Stress, and Malnutrition: Functional Correlates, Nutritional Intervention. J. M. Kinney and H. N. Tucker, editors. Lippincott-Raven Publishers, Philadelphia, PA. 303-323.
24. Karpe, F., S. M. Humphreys, J. S. Samra, L. K. Summers, and K. N. Frayn. 1997. Clearance of lipoprotein remnant particles in adipose tissue and muscle in humans. J. Lipid Res. 38: 2335-2343.
25. Bland, M. 1995. An Introduction to Medical Statistics. Oxford University Press, Oxford.
26. Byrne, C. D., N. P. Brindle, T. W. Wang, and C. N. Hales. 1991. Interaction of non-esterified fatty acid and insulin in control of triacylglycerol secretion by Hep G2 cells. Biochem. J. 280: 99-104.
27. Durrington, P. N., R. S. Newton, D. B. Weinstein, and D. Steinberg. 1982. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by rat hepatocytes. J. Clin. Invest. 70: 63-73.
28. Gibbons, G. F. 1990. Assembly and secretion of hepatic very-low-density lipoprotein. Biochem. J. 268: 1-13.
29. Patsch, W., S. Franz, and G. Schonfield. 1983. Role of insulin in lipoprotein secretion by cultured rat hepatocytes. J. Clin. Invest. 71: 1161-1174.
30. Sparks, J. D., and C. E. Sparks. 1994. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim. Biophys. Acta. 1215: 9-32.
31. Coppack, S. W., K. N. Frayn, S. M. Humphreys, H. Dhar, and T. D. Hockaday. 1989. Effects of insulin on human adipose tissue metabolism in vivo. Clin. Sci. 77: 663-670.
32. Lewis, G. F., K. D. Uffelman, L. W. Szeto, B. Weller, and G. Steiner. 1995. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J. Clin. Invest. 95: 158-166.
33. Brown, A-M., D. Wiggins, and G. F. Gibbons. 1999. Glucose phosphorylation is essential for the turnover of neutral lipid and the second stage assembly of triacylglycerol-rich apoB-containing lipoproteins in primary hepatocyte culture. Arterioscler. Thromb. Vasc. Biol. 19: 321-329.
34. Sidossis, L. S., B. Mittendorfer, E. Walser, D. Chinkes, and R. R. Wolfe. 1998. Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am. J. Physiol. 275: E798-E805.
35. Wolfe, R. R. 1998. Metabolic interaction between glucose and fatty acids in humans. Am. J. Clin. Nutr. 67 (Suppl 3): 519S-526S.
36. Wolfe, R. R., J. H. F. Shaw, and M. J. Durkot. 1985. Effect of sepsis on VTDL kinetics: responses in basal state and during glucose infusion. Am. J. Physiol. 248: E732-E740.
37. Thomas, E. L., N. Saeed, J. V. Hajnal, A. Brynes, A. P. Goldstone, G. Frost, and J. D. Bell. 1998. Magnetic resonance imaging of total body fat. J. Appl. Physiol. 85: 1778-1785.
38. Van Harmelen, V., F. Löoqvist, A. Thörne, A. Wennlund, V. Large, S. Reynisdottir, and P. Arner. 1997. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects. Int. J. Obes. Relat. Metab. Disord. 21: 972-979.
39. Cohen, J. C., and G. M. Berger. 1990. Effects of glucose ingestion on postprandial lipemia and triglyceride clearance in humans. J. Lipid Res. 31: 597-602.
40. Havel, R. J., E. O. Kane, N. Balasse, N. Segel, and L. V. Basso. 1970. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J. Clin. Invest. 49: 2017-2035.
41. Boberg, J., L. A. Carlson, and U. Freyschuss. 1972. Determination of splanchnic secretion rate of plasma triglycerides and of total and splanchnic turnover of plasma free fatty acids in man. Eur. J. Clin. Invest. 2: 123-132.
42. Schwarz, J. M., R. A. Neese, S. Turner, D. Dare, and M. K. Hellerstein. 1995. Short-term alterations in carbohydrate energy intake in humans. Striking effects on hepatic glucose production, de novo lipogenesis, lipolysis, and whole-body fuel selection. J. Clin. Invest. 96: 2735-2743.
43. Cummings, M. H., G. F. Watts, C. Pal, M. Umpleby, T. R. Hennessy, R. Naoumova, and P. H. Sonksen. 1995. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: a stable isotope study. Clin. Sci. Colch. 88: 225-233.
44. Malmström, R., C. J. Packard, T. D. Watson, S. Rannikko, M. Caslake, D. Bedford, P. Stewart, H. Yki-Järvinen, J. Shepherd, and M. R. Taskinen. 1997. Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler. Thromb. Vasc. Biol. 17: 1454-1464.
45. Turner, P. R., N. E. Miller, C. Cortese, W. Hassard, J. Coltart, and B. Lewis. 1981. Splanchnic metabolism of plasma apoB. Studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects. J. Clin. Invest. 67: 1678-1686.
46. Taskinen, M. R., W. F. Beltz, I. Harper, R. M. Fields, G. Schonfeld, S. M. Grundy, and B. V. Howard. 1986. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism. Studies before and after sulfonylurea therapy. Diabetes. 35: 1268-1277.